Intravenous immunoglobulin in necrotizing fasciitis - A case report and review of recent literature

Annals of Medicine and Surgery

Volumn 4, Issue 3, 2015, Pages 260-263

  Koch, C ^a   Hecker, A ^a   Grau, V ^a   Padberg, W ^a   Wolff, M ^a   Henrich, M ^a  

^a UNIVERSITY HOSPITAL GIESSEN   (Germany)

Author keywords

Fasciitis; Immunoglobulin; IVIg; Necrotizing; Sepsis; Soft skin and tissue infection

Indexed keywords

CEFUROXIME; CLINDAMYCIN; IMMUNOGLOBULIN; MEROPENEM; PENICILLIN G;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; FOLLOW UP; HUMAN; INTENSIVE CARE; LABORATORY TEST; LOADING DRUG DOSE; MALE; NECROTIZING FASCIITIS; PAIN; PHYSICAL EXAMINATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 84939181161     PISSN: 20490801     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amsu.2015.07.017     Document Type: Article

References (25)

1. Wilson B. Necrotizing fasciitis. Am. Surg. 1952, 18:416-431.
2. Childers B.J., Potyondy L.D., Nachreiner R., Rogers F.R., Childers E.R., Oberg K.C., et al. Necrotizing fasciitis: a fourteen-year retrospective study of 163 consecutive patients. Am. Surg. 2002, 68:109-116.
3. Lewis R.T. Soft tissue infections. World J. Surg. 1998, 22:146-151.
4. Sudarsky L.A., Laschinger J.C., Coppa G.F., Spencer F.C. Improved results from a standardized approach in treating patients with necrotizing fasciitis. Ann. Surg. 1987, 206:661-665.
5. Puvanendran R., Huey J.C.M., Pasupathy S. Necrotizing fasciitis. Can. Fam. Phys. 2009, 55:981-987.
6. Shimizu T., Tokuda Y. Necrotizing fasciitis. Intern. Med. 2010, 49:1051-1057. 10.2169/internalmedicine.49.2964.
7. Elliott D., Kufera J.A., Myers R.A. The microbiology of necrotizing soft tissue infections. Am. J. Surg. 2000, 179:361-366.
8. Singh G., Ray P., Sinha S.K., Adhikary S., Khanna S.K. Bacteriology of necrotizing infections of soft tissues. Aust. N. Z. J. Surg. 1996, 66:747-750.
9. Sartelli M., Malangoni M.A., May A.K., Viale P., Kao L.S., Catena F., et al. World society of emergency surgery (WSES) guidelines for management of skin and soft tissue infections. World J. Emerg. Surg. 2014, 9:57. 10.1186/1749-7922-9-57.
10. Elliott D.C., Kufera J.A., Myers R.A. Necrotizing soft tissue infections. Risk factors for mortality and strategies for management. Ann. Surg. 1996, 224:672-683.
11. Bilton B.D., Zibari G.B., McMillan R.W., Aultman D.F., Dunn G., McDonald J.C. Aggressive surgical management of necrotizing fasciitis serves to decrease mortality: a retrospective study. Am. Surg. 1998, 64:397-400. Discussion 400-1.
12. Francis K.R., Lamaute H.R., Davis J.M., Pizzi W.F. Implications of risk factors in necrotizing fasciitis. Am. Surg. 1993, 59:304-308.
13. Edlich R.F., Cross C.L., Dahlstrom J.J., Long W.B. Modern concepts of the diagnosis and treatment of necrotizing fasciitis. J. Emerg. Med. 2010, 39:261-265. 10.1016/j.jemermed.2008.06.024.
14. Misiakos E.P., Bagias G., Patapis P., Sotiropoulos D., Kanavidis P., Machairas A. Current concepts in the management of necrotizing fasciitis. Front. Surg. 2014, 1:36. 10.3389/fsurg.2014.00036.
15. Mulla Z.D. Treatment options in the management of necrotising fasciitis caused by Group A Streptococcus. Expert Opin. Pharmacother. 2004, 5:1695-1700. 10.1517/14656566.5.8.1695.
16. Carapetis J.R., Jacoby P., Carville K., Ang S.-J.J., Curtis N., Andrews R. Effectiveness of clindamycin and intravenous immunoglobulin, and risk of disease in contacts, in invasive group a streptococcal infections. Clin. Infect. Dis. 2014, 59:358-365. 10.1093/cid/ciu304.
17. Waddington C.S., Snelling T.L., Carapetis J.R. Management of invasive Group A streptococcal infections. J. Infect. 2014, 69(Suppl. 1):S63-S69. 10.1016/j.jinf.2014.08.005.
18. Takei S., Arora Y.K., Walker S.M. Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens [see comment]. J. Clin. Investig. 1993, 91:602-607. 10.1172/JCI116240.
19. Norrby-Teglund A., Kaul R., Low D.E., McGeer A., Newton D.W., Andersson J., et al. Plasma from patients with severe invasive Group A streptococcal infections treated with normal polyspecific IgG inhibits streptococcal superantigen-induced T cell proliferation and cytokine production. J. Immunol. 1996, 156:3057-3064.
20. Wang J., McQuilten Z.K., Wood E.M., Aubron C. Intravenous immunoglobulin in critically ill adults: when and what is the evidence?. J. Crit. Care 2015 Jun, 30(3):652.e9-652.e16. 10.1016/j.jcrc.2015.01.022.
21. Foster R., Suri A., Filate W., Hallett D., Meyer J., Ruijs T., et al. Use of intravenous immune globulin in the ICU: a retrospective review of prescribing practices and patient outcomes. Transfus. Med. 2010, 20:403-408. 10.1111/j.1365-3148.2010.01022.x.
22. Kaul R., McGeer A., Norrby-Teglund A., Kotb M., Schwartz B., O'Rourke K., et al. Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome-a comparative observational study. The Canadian Streptococcal Study Group. Clin. Infect. Dis. 1999, 28:800-807. 10.1086/515199.
23. Darenberg J., Ihendyane N., Sjölin J., Aufwerber E., Haidl S., Follin P., et al. Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial. Clin. Infect. Dis. 2003, 37:333-340. 10.1086/376630.
24. Young M.H., Engleberg N.C., Mulla Z.D., Aronoff D.M. Therapies for necrotising fasciitis. Expert Opin. Biol. Ther. 2006, 6:155-165. 10.1517/14712598.6.2.155.
25. Sarani B., Strong M., Pascual J., Schwab C.W. Necrotizing fasciitis: current concepts and review of the literature. J. Am. Coll. Surg. 2009, 208:279-288. 10.1016/j.jamcollsurg.2008.10.032.